Also listed on Accel Biotech, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 9, 2036 · High confidence
20-year base term ends Oct 3, 2036
Held by Roche Molecular Systems, Inc.
Filed Oct 3, 2016 as application 15/283,797 · Granted Jul 16, 2019
Base term plus 37 days of patent term adjustment (USPTO delay)
Today
2016
2036
Clock starts
Oct 3, 2016
Oct 3, 2016
Term ends
Nov 9, 2036
Nov 9, 2036
Granted
Jul 16, 2019
Jul 16, 2019
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
37
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 37 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 3, 2016, when this application, 15/283,797, was filed | Oct 3, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +37 days, USPTO patent term adjustment record | Nov 9, 2036 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 9, 2036 | High confidence |
This family
| Application 62/237,177 | Provisional application no patent term | no patent term |
| US 10,351,893 | this patent Nov 2036 | Nov 2036 |
| US 11,149,295 | Lapsed on the fee record Oct 2025 | Oct 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 3, 2017 Reel 43771, frame 273 | Frei, Werner; Donnelly, Doran; Page, Lance; Roy, Shaunak | Geneweave Biosciences, Inc. | Assignment of Assignor's Interest |
| Oct 6, 2017 Reel 43803, frame 148 | Griswold, Ryan C. | Accel Biotech, Inc. | Assignment of Assignor's Interest |
| Dec 5, 2017 Reel 44303, frame 687 | Accel Biotech, LLC | Geneweave Biosciences, Inc. | Assignment of Assignor's Interest |
| Dec 5, 2017 Reel 44696, frame 732 | Griswold, Ryan C. | Accel Biotech, LLC | Corrective Assignment to Correct the Name of Assignee to Accel Biotech, LLC Previously Recorded on Reel 043803 Frame 0148. Assignor(S) Hereby Confirms the Assignment of Assignors Interest. |
| Jul 23, 2021 Reel 56964, frame 395 | Geneweave Biosciences, Inc. | Roche Molecular Systems, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2036
Term ends Nov 9, 2036. Maintenance fees still fall due before then
Note
The 37 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
4
later US patents cite this one
That is above the median of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.